In this issue:
- Tisotumab vedotin for recurrent cervical cancer
- Open vs minimally invasive radical hysterectomy for early-stage cervical cancer
- Screening for Lynch syndrome in endometrial cancer diagnoses
- Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer
- Endometriosis typology and ovarian cancer risk
- Cell-free DNA from ascites in advanced ovarian cancer
- Exercise and sitting time during chemotherapy
- Mirvetuximab soravtansine in platinum-resistant ovarian cancer
- Global burden of gynaecological cancers
- Nivolumab for dMMR gynaecologic cancers
Please login below to download this issue (PDF)